Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate mofetil for collagen vascular disease–associated interstitial lung disease
jRCT1091220173Completed
- Sponsor
- Toshinori Takada
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of mycophenolate mofetil in interstitial lung disease (ILD) and pulmonary fibrosis secondary to systemic sclerosis (SSc-ILD) (2 arms), sponsored by Toshinori Takada. Primary endpoint: Safety of mycophenolate mofetil. Started Mar 2014; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
interstitial lung disease (ILD)pulmonary fibrosis secondary to systemic sclerosis (SSc-ILD)
Beyond the preview
Go deeper on jRCT1091220173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220173.